Abstract
The discrimination and evaluation of stereoselective metabolism of enantiomers are of paramount significance for developing effective and safe chiral drugs. However, there is still a lack of comprehensive and in-depth understanding of stereospecific disposition of chiral components in Herbal Medicines. In this article, stereoselective methods including capillary electrophoresis, high-performance liquid chromatography, gas chromatography, supercritical fluid chromatography and hyphenation techniques for chiral drug metabolism studies are reviewed. Furthermore, applications of modern analytical techniques to study enantioselective metabolic profiling of the active components from Herbal Medicines in vitro and in vivo in recent years are also presented and the representative examples are enumerated.
Keywords: Chiral analysis, Drug metabolism, Pharmacokinetics, Herbal medicines
Current Pharmaceutical Analysis
Title: Stereoselective Metabolic and Pharmacokinetic Analysis of the Chiral Active Components from Herbal Medicines
Volume: 6 Issue: 1
Author(s): Xiaowen Wang and Su Zeng
Affiliation:
Keywords: Chiral analysis, Drug metabolism, Pharmacokinetics, Herbal medicines
Abstract: The discrimination and evaluation of stereoselective metabolism of enantiomers are of paramount significance for developing effective and safe chiral drugs. However, there is still a lack of comprehensive and in-depth understanding of stereospecific disposition of chiral components in Herbal Medicines. In this article, stereoselective methods including capillary electrophoresis, high-performance liquid chromatography, gas chromatography, supercritical fluid chromatography and hyphenation techniques for chiral drug metabolism studies are reviewed. Furthermore, applications of modern analytical techniques to study enantioselective metabolic profiling of the active components from Herbal Medicines in vitro and in vivo in recent years are also presented and the representative examples are enumerated.
Export Options
About this article
Cite this article as:
Wang Xiaowen and Zeng Su, Stereoselective Metabolic and Pharmacokinetic Analysis of the Chiral Active Components from Herbal Medicines, Current Pharmaceutical Analysis 2010; 6 (1) . https://dx.doi.org/10.2174/157341210790780221
DOI https://dx.doi.org/10.2174/157341210790780221 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of Polygonum bistorta for Anticancer Potential Using Selected Cancer Cell Lines
Medicinal Chemistry Production of Lentivectors for Clinical Use
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) T-Cell Zeta Chain Expression, Phosphorylation and Degradation and their Role in T-Cell Signal Transduction and Immune Response Regulation in Health And Disease
Current Signal Transduction Therapy Proteasome Inhibitors Therapeutic Strategies for Cancer
Recent Patents on Anti-Cancer Drug Discovery A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Anti-Cancer Agents in Medicinal Chemistry Threes Company: Regulation of Cell Fate by Statins
Current Drug Targets - Cardiovascular & Hematological Disorders N-Hydroxyguanidines as Substrates of Nitric Oxide Synthases
Current Topics in Medicinal Chemistry α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents
Anti-Cancer Agents in Medicinal Chemistry In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
Current Pharmaceutical Design Notch-Associated MicroRNAs in Cancer
Current Drug Targets The Role of CXC-Chemokine IL-8, IL-6 and CXCR2 Receptor in Lymphoplasmacytic Lymphoma: Correlations with Microvascular Characteristics and Clinical Features
Current Angiogenesis (Discontinued) Melatonin a Promising Candidate for DNA Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations
Anti-Cancer Agents in Medicinal Chemistry Laccases in Pharmaceutical Chemistry: A Comprehensive Appraisal
Mini-Reviews in Organic Chemistry Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy
Current Pharmaceutical Design Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Current Pharmaceutical Biotechnology De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment
Current Pharmaceutical Design Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias
Anti-Cancer Agents in Medicinal Chemistry In Situ Gene Therapy for Prostate Cancer
Current Gene Therapy Ocular Toxicities in Cancer Therapy: Still Overlooked
Current Cancer Therapy Reviews